CAMK2G and cardiac hypertrophy: The β-adrenergic receptor (β-AR)/ cAMP/ PKA/ signaling pathway is one of the most well-characterized pathways, and downstream molecules, including CaMKII, have been reported to introduce pathological cardiac hypertrophy, associated with reduced cardiac function24.